We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Algenex has opened its new facility in Tres Cantos, Spain. The new facility allows Algenex to produce up to 3.5kg of recombinant proteins, equivalent to around 100 million vaccine doses across animal and human health.